Chris Griffith was invited to speak at the 9th Asia Pharma R&D Leaders Conference in Beijing held on January 21-22, 2019.
This event provided a strategic platform for companies, academia and other stakeholders in the Asia biopharma industry to meet, communicate and establish partnerships. Chris presented on “Navigating the IP Waters – Portfolio Development, FDA Exclusivities and Current Legal Issues Affecting the Journey Toward Commercialization of Biopharmaceutical Products in the US.”
For more information on our practice, please contact us.
